The Globally Harmonized System (GHS) on hazard classiˆcation and labeling of chemicals will be implemented globally by 2008. The GHS includes (a) harmonized criteria for classifying chemicals and chemical mixtures according to their health, environmental and physical hazards, and (b) harmonized hazard communication elements, including requirements for labeling and safety data sheets. Germ cell mutagenicity is included in the GHS health hazard classes in addition to carcinogenicity. This means increased signiˆcance for then results of genetic toxicology testing for the classiˆcation of chemicals. GHS requires the classiˆcation of chemicals if they are germ cell mutagens (categories 1A, 1B and 2) or not. Several classiˆcation systems for germ cell mutagens have been proposed in the EU, Germany, US, Canada, in advance of the adoption of the GHS. In this paper, these classiˆcation systems including GHS are introduced and summarized to provide the basis of the hazard classiˆcation of germ cell mutagens. Though the objectives, target audiences and criteria of these classiˆcation systems are diŠerent, the GHS will become standard for hazard classiˆcation. Hazard classiˆ-cation is a signiˆcantˆrst step in risk communication. Further development of risk evaluation criteria and communication on germ cell mutagens is expected.
Introduction
The Globally Harmonized System (GHS) of classiˆ-cation and labeling of chemicals is a single, globally harmonized system to address classiˆcation of chemicals, labelling, and safety data sheets, which has been developed by the United Nations (UN). The GHS document has been prepared and published by the secretariat of the United Nations Economic Commission for Europe (1, 2) . The GHS covers all hazardous chemicals except for pharmaceuticals, food additives, cosmetics, and pesticide residues in food in terms of labeling at the point of intentional intake. The GHS is based on currently available data and thus compliance with these criteria will not require retesting of chemicals for which acceptable test data already exists.
The goal of the GHS is to identify the intrinsic hazards found in chemicals and chemical mixtures and to convey the information about these hazards to the target audiences including consumers, workers, transport workers, and emergency responders. The World Summit on Sustainable Development in Johannesburg on 4th September, 2002 encouraged countries to implement the GHS as soon as possible with a view to having the system fully operational by 2008. In Japan, an interministerial committee was organized in 2001 to share information about the GHS among ministries and to play a pivotal role in the UN-Subcommittee. Seven government o‹ces, i.e., Ministry of Health, Labour and Welfare (MHLW), Ministry of Economy, Trade and Industry (METI), Ministry of the Environment (MOE), Ministry of Internal AŠairs and Communications (MIC), Ministry of Agriculture, Forestry and Fisheries (MAFF), Ministries of Land Infrastructure and Transport (MLIT) and Ministry of Foreign AŠairs (MOFA), and experts from national laboratories and industries participated in the committee. The committee's activities include: (i) translation of the GHS into Japanese (3); (ii) information sharing among ministries with respect to the relevant domestic laws; (iii) classiˆca-tion of chemicals under each relevant domestic law (4); and (iv) deliberation on the agenda items and documents of the UN Sub-Committee meetings and decisionmaking about the Japanese position.
The GHS includes the following two elements: harmonized criteria for classifying substances and mixtures according to their health (10 hazard classes), environmental (1 hazard class) and physical hazards (16 hazard classes); and harmonized hazard communication elements, including requirements for labeling and safety data sheets. The GHS requests classiˆcation of the following 10 hazard classes in health hazard, i.e., (i) acute toxicity, (ii) skin corrosion/irritation, (iii) serious eye damage/eye irritation, (iv) respiratory or skin sensitization, (v) germ cell mutagenicity, (vi) carcinogenicity, (vii) reproductive toxicity, (viii) speciˆc target organ systemic toxicity-single exposure, (ix) speciˆc target organ systemic toxicity-repeated exposure, and (x) aspiration hazard.
It is striking that not mutagenicity per se but germ cell mutagenicity speciˆcally is included in GHS health hazard class in addition to carcinogenicity. The GHS focuses on heritable eŠects by mutagens. Several classiˆcation systems of mutagens or germ cell mutagens have been proposed from European Union (EU), Germany, United States of America (US), Canada, etc. The criteria for germ cell mutagens of GHS and other systems are reviewed and summarized to aid understanding of the control of chemicals by these regulations.
Classiˆcation Systems for Germ Cell Mutagens
Classiˆcation systems for mutagens or germ cell mutagens in GHS, EU, Germany, USA, Canada, and Japan are described below.
GHS: In the GHS (2), the term``mutation'' applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modiˆcations when known (including, for example, speciˆc base pair changes and chromosomal translocations). The term``mutagenic'' and``mutagen'' will be used for chemicals giving rise to an increased occurrence of mutations in populations of cells and/or organisms. The more general terms``genotoxic'' and``genotoxicity'' apply to chemicals or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a nonphysiological manner (temporarily) alter its replication.
In order to achieve classiˆcation, GHS states that Test results are considered from experiments determining mutagenic and/or genotoxic eŠects in germ and/or somatic cells of exposed animals. The system is hazard based, classifying chemicals on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of chemical substances. Classiˆcation for heritable eŠects in human germ cells is made on the basis of well conducted, su‹ciently validated tests, preferably as described in OECD Test Guidelines. Evaluation of the test results should be done using expert judgment and all the available evidence should be weighed for classiˆcation. The classiˆcation of individual substances should be based on the total weight of evidence available, using expert judgment. In those instances where a single well-conducted test is used for classiˆcation, it should provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the chemical compared to the route of human exposure should also be taken into account. ' The criteria for classiˆcation of germ cell mutagens places chemicals in one of three categories, category 1 being used for chemicals known to induce heritable mutations (category 1A) or known to be regarded as if they induce heritable mutations in germ cells of humans (category 1B); category 2 for chemicals which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans (2) . The criterion for category 1A is positive evidence from human epidemiological studies. The criteria for category 1B are as follows: (i) positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or (ii) positive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has the potential to cause mutations to germ cells. This supporting evidence may, for example, be derived from mutagenicity/genotoxic tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or (iii) positive results from tests showing mutagenic eŠects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in the sperm cells of exposed people. The criteria for category 2 are positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from: (i) somatic cell mutagenicity tests in vivo, in mammals; or (ii) other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays. In addition, following criteria are included as Note: Chemicals which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, should be considered for classiˆcation as Category 2 mutagens.
If there are not enough data for the evaluation of mutagenicity of the chemical, it regards as``classiˆca-tion not possible'' (Fig. 1) . If there is no concern of induction of heritable mutations in the germ cells of humans or insu‹cient evidence for inclusion in category 1 or 2, the chemicals are regarded as``not classiˆed''. Hazard categories and their criteria for germ cell mutagens in GHS are summarized in Table 1 . For classiˆcation of chemical mixtures, the mixture will be Fig. 1 . Decision logic for the classiˆcation of germ cell mutagens in GHS (2) classiˆed as a mutagen when at least one ingredient has been classiˆed as a category 1 or category 2 mutagen and is present at or above the cut-oŠ value/concentration limits below for category 1 (AE0.1z) or category 2 (AE1.0z), respectively.
European Union (EU): The criteria for classiˆcation of mutagens in EU are described in Commission directive (5, 6). There are three categories: substances known to be mutagenic to human (category 1) for which there is su‹cient evidence to establish a causal association between human exposure to the chemical and heritable genetic damage; substances which should be regarded as if they were mutagenic to human (category 2) for which there is su‹cient evidence to provide a strong presumption that human exposure to the chemical may result in the development of heritable genetic damage, generally on the basis of appropriate animal studies and other relevant information; substances which cause concern for humans owing to possible mutagenic eŠect (category 3) for which there is evidence from appropriate mutagenicity studies, but it is insu‹cient to place the substance in category 2. EU criteria for classiˆcation of chemicals are summarized in Table 2 .
This system is primarily based on intrinsic hazard, despite the statement in the Annex (7) that`the object of classiˆcation is to identify all the physicochemical, toxicological and ecotoxicological properties of substances and preparations which may constitute a risk during normal handling or use' (4).
Germany: Maximale Arbeitsplatz-Konzentration (MAK) Commission in Germany proposed 5 categories for classiˆcation of germ cell mutagens at the workplace (8, 9) . These are germ cell mutagens which have been shown to increase the mutant frequency in the progeny of exposed humans (category 1); germ cell mutagens which have been shown to increase the mutant frequency in the progeny of exposed mammals (category 2); chemicals which have been shown to induce genetic damage in germ cells of humans and/or animals, or which produce mutagenic eŠects in somatic cells of mammals in vivo and the chemicals have been shown to reach the germ cells in an active form (category 3A); chemicals which are suspected of being germ cell mutagens because of their genotoxic eŠects in mammalian somatic cells in vivo; in exceptional cases, chemicals for which there are no in vivo data but which are clearly mutagenic in vitro and structurally related to known in vivo mutagens (category 3B); and germ cell mutagens, the potency of which is considered to be so low that, provided the MAK value (Maximum Concentration at the Workplace) is observed, their contribution to genetic risk for man is expected not to be signiˆcant (category 5). Category 4 is not applicable in germ cell mutagenicity because this classiˆcation system has been established in analogy to the categories for carcinogenic chemicals. Category 4 carcinogenic substances are those with non-genotoxic mechanisms of action. By deˆni-tion, germ cell mutagens are genotoxic. MAK categories and criteria for classiˆcation of germ cell mutagens are summarized in Table 3 . The MAK Commission describes germ cell mutagenicity as follows (9):`Germ cell mutagens produce heritable gene mutations, and heritable structural and numerical chromosome aberrations in germ cells. The consequences of germ cell mutations in subsequent generations include genetically determined phenotypic alterations without signs of illness, reduction in fertility, embryonic or perinatal death, more or less severe congenital malformations, and genetic diseases with various degrees of health impairment. The term``germ cell mutagenicity'' refers speciˆcally to mutagenicity in male and female germ cells and is distinguished from mutagenicity in somatic cells, which can initiate cancer. Epidemiological studies, however, have been unable to Although structural changes have been demonstrated in the chromosomes of the germ cells of men exposed to radiation, even thisˆnding can only provide indirect evidence that such exposures could lead to hereditary disorders in the oŠspring. The proof that an increased frequency of hereditary diseases is related to a particular exposure would be associated with great methodological di‹culties. In the human population there are a large number of hereditary diseases of unknown origin with frequencies that diŠer widely in diŠerent subpopulations. Since mutational events occur largely randomly in the genome, it is not to be expected that one particular substance would induce one characteristic genetic disease. Therefore, it is most unlikely that proof of a Table 3 . Categories for classiˆcation of germ cell mutagens by MAK commission (8, 9) Category Classiˆcation Criteria Category 1 Substances shown to increase the mutant frequency in the progeny of exposed humans
In the section`Epidemiological methods and their limitations' it is explained why epidemiological studies to date have not been able to prove that the exposure of a particular human population to a particular substance has resulted in an increase in the incidence of inherited mutations. This is true both for ionizing radiation and chemical mutagens. Even if epidemiological methods are improved further, it is unlikely that such proof will be available in the foreseeable future. Category 1 will therefore probably remain without any entries.
Category 2 Substances shown to increase the mutant frequency in the progeny of exposed mammals Classiˆed as category 2 are substances that increase the incidence of genetically modiˆed live progeny in animal studies, for example in the speciˆc locus test or in the test for heritable translocations. Likewise, substances that should be classiˆed as category 2 are those that increase the incidence of embryos that die in utero, for example in the dominant lethal test.
Category 3A Substances shown to induce genetic damage in germ cells of humans or animals, or which produce mutagenic eŠects in somatic cells of mammals in vivo and shown to reach the germ cells in an active form
The methods include tests for genotoxicity in germ cells of experimental animals, such as tests for induction of structural chromosomal changes in spermatogonia or spermatocytes, for sister chromatid exchange in spermatogonia, for micronuclei in round spermatids, for numerical chromosome changes in secondary spermatocytes or in spermatozoa, for DNA single strand breaks and for repair synthesis or for covalent binding to the DNA. Also relevant are the observations obtained from exposed human populations which provide evidence for structural or numerical chromosome changes in spermatozoa of exposed persons. Category 3B Substances suspected of germ cell mutagens because of their genotoxic eŠects in mammalian somatic cells in vivo; in exceptional cases, substances without in vivo data but with clearly mutagenic in vitro and structurally related to known in vivo mutagens
If the available data are not su‹cient for classiˆcation in category 3A but the substance is clearly genotoxic in somatic cells of exposed animals or humans, the substance is also suspected of being mutagenic in germ cells. Substances that have yielded positive results in one or several in vitro mutagenicity tests generally not classiˆed as category 3B. An exception is made for substances for which there are no relevant in vivo data but which are clearly genotoxic in vitro and also structurally related to substances known to be genotoxic in vivo. Such substances raise concern and are classiˆed as category 3B.
Category 4
Not applicable Category 4 carcinogenic substances are those with non-genotoxic mode of action. By deˆnition, germ cell mutagens are genotoxic. Therefore, a category 4 for germ cell mutagens cannot exist. Depending on future research results, a category 4 could be deˆned at a later time for genotoxic substances with targets other than DNA (i.e., pure aneugens).
Category 5
Substances considered the potency is considered so low, their contribution to genetic risk for man is expected not to be signiˆcant Substances classiˆed as category 5 are not expected to contribute signiˆcantly to the genetic risk for humans provided the MAK value is observed. For classiˆcation in this category, information on the spectrum of eŠects and their dose-dependence, and toxicokinetic data for species comparison are required. Biochemical and biological end-points can be used to characterize the contribution to genetic risk. The contribution to genetic risk is considered not to be signiˆcant after exposure at the workplace if the internal exposure level of the substance or its biomarkers is in the range of the background levels in a not speciˆcally exposed reference population: ＠ Under workplace conditions the levels of biochemical eŠect markers such as DNA and protein adducts are not signiˆcantly increased above the background levels.
＠ Physiological-toxicokinetic model calculations based on animal data do not reveal a signiˆcant genetic risk for humans.
causal relationship between exposure to a chemical and occurrence of heritable diseases will become available in the foreseeable future. In this situation, for the identiˆ-cation of germ cell mutagens the results of animal experiments must be given particular attention. The mutagenic eŠect of chemicals on the germ cells of exposed parent animals can be demonstrated by observing an increased mutant frequency among the progeny. In addition, the demonstration of genotoxic eŠects of a substance in germ cells or somatic cells provides evidence of a potential hazard for subsequent generations.' United States of America (US): US EPA: A classiˆcation using the following three categories of germ cell mutagens was proposed by the US Environmental Protection Agency (EPA) in 1984 for the evaluation of chemicals with respect to their ability to induce mutations in mammalian germ cells (10, 11) . Category I is based on su‹cient evidence obtained from at least one in vivo mammalian germ cell mutation test or from at least two in vivo somatic cell mutation tests (point mutation and/or chromosomal aberrations), plus su‹cient in vivo evidence that the chemical interacts with mammalian germ cells. Category II is based on suggestive evidence provided from positive results of in vivo somatic cell mutation tests plus evidence for interaction of the chemical with mammalian germ cells, but the evidence is insu‹cient to place the chemical in Category I. Category III is based on limited evidence of in vivo mutagenic activity or interaction of the chemical with mammalian germ cell DNA or other chromatin constituents. In 1986, guidelines for a``weight-ofevidence'' approach to human germ cell mutagenicity were established, leading to eight categories with a decreasing order of strength of evidence (10) . In addition, a``non-mutagen'' category and a category for substances with inadequate evidence were described. The eight categories of evidence are as follows: (i) positive data derived from human germ cell mutagenicity studies; (ii) valid positive results from studies on heritable mutational events (of any kind) in mammalian germ cells; (iii) valid positive results from mammalian germ cell chromosome aberration studies that do not involve transmission from one generation to the next; (iv) su‹cient evidence for a chemical's interaction with mammalian germ cells, together with valid positive mutagenicity test results from two assay systems, at least one of which is mammalian (in vivo or in vitro). The positive results may be both for gene mutation and chromosomal aberrations in mammalian systems; (v) suggestive evidence for a chemical's interaction with mammalian germ cells, together with valid positive mutagenicity evidence from two assay systems as described above under #iv. Alternatively, positive mutagenicity evidence of less strength than deˆned under #iv, when combined with su‹cient evidence for a chemical's interaction with mammalian germ cells; (vi) positive mutagenicity test results of less strength than deˆned under #iv, combined with suggestive evidence for a chemical's interaction with mammalian germ cells; (vii) although deˆnitive proof of non-mutagenicity is not possible, a chemical could be operationally classiˆed as a non-mutagen for human germ cells if it gives valid negative test results for all endpoints of concern; and (viii) inadequate evidence bearing on either mutagenicity or chemical interaction with mammalian germ cells.
This system is for the classiˆcation for transmissible germ cell genetic risk. The Guideline (10) describes Evidence that an agent induces heritable mutations in human beings could be derived from epidemiologic data indicating a strong association between chemical exposure and heritable eŠects. It is di‹cult to obtain such data because any speciˆc mutation is a rare event, and only a small fraction of the estimated thousands of human genes and conditions are currently useful as markers in estimating mutation rates. Human genetic variability, small numbers of oŠspring per individual and long generation times further complicate such studies. In addition, only disorders caused by dominant mutations, some sex-linked recessive mutations, and certain chromosome aberrations can be detected in thê rst generation after their occurrence. Conditions caused by autosomal recessive disorders (which appear to occur more frequently than dominant disorders) or by polygenic traits may go unrecognized for many generations. Therefore, in the absence of human epidemiological data, it is appropriate to rely on data from experimental animal systems as long as the limitations of using surrogate and model systems are clearly stated. Despite species diŠerences in metabolism, DNA repair, and other physiological processes aŠecting chemical mutagenesis, the virtual universality of DNA as the genetic material and of the genetic code provides a rationale for using various nonhuman test systems to predict the intrinsic mutagenicity of test chemicals. Additional support for the use of nonhuman systems is provided by the observation that chemicals causing genetic eŠects in one species or test system frequently cause similar eŠects in other species or systems. Evidence also exists that chemicals can induce genetic damage in somatic cells of exposed humans. Furthermore, a wide variety of diŠerent types of mutations have been observed in humans, including numerical chromosome aberrations, translocations, base-pair substitutions, and frameshift mutations. Although the cause of these mutations is uncertain, it is clear from these observations that human germ-cell DNA is subject to the same types of mutational events that are observed in other species and test systems. ' Recent US EPA proposals: Dearˆeld et al. from This can include cytogenetic endpoints in tissues (such as lymphocytes) from exposed persons.
Positive in human in vivo germ cell mutagenicity studies. Human germ cell mutagens.
This is based on positive in vivoˆndings from appropriate germ cell targets in exposed humans. It is recognized that a human germ cell mutagen is not currently identiˆed.
Probable human mutagen
Clear evidence for genotoxic activity in vivo mammalian test(s), usually supported by in vitro test(s). Usually animal carcinogens and may be human carcinogens.
Classiˆcation at this level usually means that some in vivo testing has been performed as follow-up to positive results from in vitro testing. Therefore, there is usually some supporting positive evidence from in vitro testing. Alternatively, it should produce positive results for DNA strand breaks (e.g. comet test), UDS, SCE and/or chromosome aberrations in germinal cells.
Possible human mutagen
Some evidence for genotoxic activity. May be carcinogenic through genotoxic mechanisms; possibly in humans.
Conˆrmed positive results may be seen in the in vitro test systems without supporting evidence from the in vivo assays. Agents falling into this category are considered to have intrinsic mutagenic potential which is not detected in vivo.
Suggestive evidence of interaction with mammalian germ cells with some evidence for genotoxic activity. May be putative human germ cell mutagens if they reach target cells.
For a test agent to be considered to present suggestive evidence of germ cell interaction, data are needed to demonstrate that: (i) the test agent shows some evidence of somatic cell mutagenicity and/or genotoxicity; (ii) the test agent reaches the gonads (e.g. data from pharmacokinetic/tissue distribution studies of the test agent and/or metabolites); (iii) the test agent interacts with germinal cells; these data come from subchronic or chronic toxicity tests showing gonadal pathology (e.g. sperm abnormalities); and (iv) the test agent causes adverse eŠects on reproductive parameters (e.g. decreased fertility, increased dead implants, reduced litter sizes).
Equivocal evidence
Results from acceptable tests that cannot be convincingly called negative or positive.
Negative evidence Negative results in acceptable tests.
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the US EPA proposed 6 categories of mutagenicity classiˆcation that are divided to 3 categories each for somatic cells and germ cells (12) . This includes (i) human somatic cell mutagens in which positive data in human somatic cells are derived from studies with exposed humans that gives positive data in human; (ii) human germ cell mutagen in which positive data from human in vivo germ cell studies are obtained; (iii) probable human somatic cell mutagen in which clear evidence for genotoxic activity from positive in vivo mammalian test(s); (iv) probable human germ cell mutagen in which su‹cient evidence of interaction with mammalian germ cells with clear evidence for genotoxic activity; (v) possible human somatic cell mutagen in which conˆrmed positive results may be seen in the in vitro test systems without supporting evidence from the in vivo assays; and (vi) possible human germ cell mutagen in which suggestive evidence of interaction with mammalian germ cells is seen. The mutagenicity classiˆcation categories proposed by Dearˆeld et al. (12) are summarized in Table 4 . The mutagenicity/genotoxicity data organized intò`c lear'' and``some'' evidence for mutagenicity and intò`s uggestive'' and``su‹cient'' evidence germ cell interaction. The classiˆcation of mutagenicity results falls into the broad categories of inadequate, negative, equivocal, and positive data. With respect to the eŠects of mutagens, Dearˆeld et al. stated that`In addition to cancer, adverse health eŠects from somatic cell mutations and/or germ cell mutations include sickle cell anemia, cardiovascular disease, reproductive/developmental eŠects, and neurobehavioral eŠects among many speciˆc and general endpoints, as well as having impact on the aging process.' (12) .
Canada: Health Canada: Health Canada proposed 6 categories of classiˆcation of chemicals with respect to their mutagenic potential for germ cells in the Canadian Environmental Protection Act (CEPA), Human Health Risk Assessment for Priority Substances (13) . Four categories have several subgroups based on the degree of evidence (Table 5 ). These classiˆcations are as follows: human germ cell mutagen (group I), for which data from adequate epidemiological studies indicate that there is a causal relationship between exposure of humans to a chemical and an increased incidence of inherited mutations in live or dead oŠspring; probable human germ cell mutagen (group II), for which data from epidemiological studies to assess germ cell mutagenicity are inadequate: however, there is su‹cient evidence of germ cell mutagenicity in animal species (i.e., there is an increased incidence of gene mutations, structural or numerical chromosomal aberrations, or inherited congenital malformations in the live oŠspring of exposed animals; or an increase in dominant lethal mutations in the potential oŠspring of exposed animals); possible human germ cell mutagen (group III); unlikely to be a human germ cell mutagen (group IV); probably not a human germ cell mutagen (group V); unclassiˆable with respect to germ cell mutagenicity in humans (group VI). Groups III, IV, V and VI have four, two, three and three subgroups, respectively (see Table 5 ).
The Canadian Environmental Protection Act (13) mentions`These eŠects including mutagenic are manifested at the biochemical, cellular, histopathological and morphological levels.', and`Chemical substances are classiˆed, therefore, with respect to their potential carcinogenicity and mutagenicity to humans; this is accomplished on the basis of rigorous examination of the quantity, quality and nature of the results of available toxicological and epidemiological studies. The criteria by which Priority Substances are classiˆed based on their weight of evidence of carcinogenicity and mutagenicity. ' Health Protection Branch: The Health Protection Branch deˆned toxicologicalˆndings that would be regarded as germ cell genotoxicity (14) . The toxicological indication of germ cell genotoxicity are (i) in vitro test results and positive evidence for mutagenicity in somatic cells in vivo, and (ii) evidence from pharmacokinetic/tissue distribution studies that the test material and/or metabolites reaches the gonads; or (iii) evidence from subchronic or chronic treatment studies that gonadal pathology indicates germ cell damage; or (iv) evidence for reproductive/developmental eŠects showing reduced numbers of pregnancies, reduced litter sizes or increased time to mating following treatment in some cases. A signiˆcant proportion of agents that cause in vivo somatic cell mutation might also possess the ability to lead to mutation in germ cells that may be transmitted to oŠspring. When evidence for in vivo somatic genotoxicity is demonstrated, along with tissue distribution, metabolic and/or pathologic evidence that the genotoxic chemical (or metabolites) reaches the germ lines (whether or not overt eŠects on fertility are found), the possibility of induced genetic damage to germ cells leading to heritable eŠects should be investigated (14) .
Canadian Centre for Occupational Health and Safety: Controlled Products Regulations (CPR) has two mutagenicity criteria (11, 15) Japan: The Japanese Industrial Safety and Health Law addresses the mutagenicity classiˆcation of substances in the workplace (11) . Under this legislation, Japan does not classify mutagenic substances according to a weight of evidence approach or whether a compound may be a somatic or germ cell mutagen but rather recognizes one category:``mutagenic''. A substance is classiˆed as mutagenic when the results of a``bacterial reverse mutation assay'' are positive. Workers' health impairment by the exposure to the`strong' mutagenic chemicals or chemical mixtures (excluding those containing 1z or less by weight of mutagenic chemicals), which induce more than 1000 revertants/mg/plate in a bacterial reverse mutation assay, should be prevented in the work for manufacture or handling of these chemicals (16) .
Future of Classiˆcation of Germ Cell Mutagens
Chemical evaluation of mutagenicity/genotoxicity has three major directions that are (i) screening of carcinogens, (ii) mechanistic investigation of carcinogenesis, and (iii) investigation of heritable adverse eŠects in germ cells including those in humans. Mutagenicity in GHS is focused on the last topic in terms of classiˆcation of germ cell mutagens. GHS and the other existing classiˆcation systems have diŠerent Group III. C ditto Data from epidemiological studies to assess germ cell mutagenicity in humans are inadequate or lacking. There is su‹cient data in animals to indicate that the chemical is a germ cell mutagen, but available data indicate that the induction of mutations occurs through an epigenetic threshold-based mechanism.
Group III. D ditto Data from epidemiological studies to assess germ cell mutagenicity in humans are inadequate. There is su‹cient evidence of mutagenicity of somatic cells in humans or animal species (in vivo gene mutations or chromosomal aberrations), but evidence of exposure to germ cells is inadequate or lacking.
Group IV. A Unlikely to Be a Human Germ Cell Mutagen There is no evidence of human germ cell mutagenicity in su‹ciently powerful and well-designed epidemiological studies. There is evidence of mutagenicity of somatic cells in well-designed and well-conducted studies in humans or animals, but there is no evidence of exposure of human or animal germ cells in well-designed studies.
Group IV. B ditto Data on germ cell mutagenicity in epidemiological studies in humans are inadequate; there is no evidence of mutagenicity in vivo in germ or somatic cells in welldesigned and properly conducted studies in animals.
Group V. A Probably Not a Human Germ Cell Mutagen There is no evidence of germ cell mutagenicity in su‹ciently powerful and welldesigned epidemiological studies; there is no evidence of germ cell mutagenicity in animal species.
Group V. B ditto There is no evidence of germ cell mutagenicity in su‹ciently powerful and welldesigned epidemiological studies; data in animal species are inadequate.
Group V. C ditto Data from epidemiological studies to assess germ cell mutagenicity in humans are inadequate, but evidence of the lack of germ cell mutagenicity in animal species is strongly supported by other data on mutagenicity in vivo.
Group VI. A Unclassiˆable with Respect to Germ Cell Mutagenicity in Humans
Data from epidemiological and/or animal studies are inadequate (i.e., because of major qualitative limitations, the studies cannot be interpreted as showing either the presence or absence of germ cell mutagenicity).
Group VI. B ditto There are no in vivo mutagenicity data available for evaluation.
Group VI. C ditto Results of epidemiological studies in human populations and experimental studies in animal species are con‰icting, without an identiˆable mechanistic basis.
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objectives, target audiences and criteria. For example, the primary objective of the systems in GHS, EU and Germany MAK is for hazard classiˆcation, on the other hand, the systems of US EPA and Health Canada are for risk assessment. Target audiences are workers in the systems of Germany MAK, Canadian CPR and Japan; consumers and workers in EU system; consumers, workers, transport workers, and emergency responders in GHS. As for criteria, the report from EPA researchers includes adverse eŠects on reproductive parameters. The fundamental purposes are diŠerent in these regulations; therefore, it is di‹cult to discuss the signiˆcance of the diŠerent approaches. Simple classiˆ-cation category and criteria will be useful for hazard classiˆcation. The GHS and EU systems on (germ cell) mutagenicity meet to this point. Application of the criteria needs expert judgment in a weight of evidence approach in GHS. However, the expert judgment leads sometimes diŠerent conclusion from expert to expert. This will be a critical issue in the classiˆcation of germ cell mutagens by GHS. Furthermore, hazard classiˆcation/evaluation is often confused as risk evaluation, especially in Japan. Further eŠorts including risk evaluation and communication on germ cell mutagenicity will be needed to make understanding of regulations global.
Recently, the European Commission proposed a new regulatory framework for chemicals called REACH for the Registration, Evaluation and Authorisation of Chemicals in October 2003 (17) . The authorisation process pays particular attention to the risks that the substance poses due to any carcinogenic, mutagenic, and/or reproductive toxicity (CMR) properties. CMR's category 1 and 2 in the EU criteria, which correspond to the category 1A and 1B, respectively in GHS criteria, are subject to authorization (18, 19) . All substances imported in quantities over 1 tonne that contain more than 0.1 per cent CMR material must be authorised before gaining access to the EU market. Authorisation provides a permit for speciˆc uses and can be requested by`producer' or`user'. The GHS itself is not legally binding, however, some national or regional laws including REACH may be legally binding. Now, classiˆ-cation of germ cell mutagens becomes an important issue.
As GHS criteria have been adopted in worldwide, it will become standard for hazard classiˆcation. After implementation of GHS in each country, the classiˆca-tion of chemicals on germ cell mutagenicity will be performed by chemical suppliers (manufacturers or importers). Understanding classiˆcation systems for germ cell mutagens will be helpful for scientiˆcally sound classiˆcation of chemicals in the GHS.
